Essentials of Oncology
for Pharmacists

Program Faculty

 

Kathy Vu, BScPhm, PharmD
Dr. Kathy Vu graduated from the University of Toronto where she obtained her Bachelor of Science degree in Pharmacy in 1999. She later went on to complete a hospital residency and her Doctor of Pharmacy degree.  Kathy’s area of specialization is in oncology where she practiced as a clinical pharmacy practitioner for 12 years and is now at Cancer Care Ontario as the Clinical Lead, Safety Initiatives.  Kathy is actively involved in the education of pharmacy and medical students, pharmacists and allied health members. She is an Assistant Professor (status), a coordinator for Patient Care Skills and Self Care courses of the International Pharmacy Graduate Program, guest  lecturer and Teaching Associate at the Leslie Dan Faculty of Pharmacy.  Kathy is also the Academic Director for the Oncology Program with the Office of Continuous Professional Development at the Faculty.

Carlo De Angelis, PharmD, RPh
Dr. Carlo earned his Bachelor of Science in Pharmacy from the University of Toronto in 1981 and completed a Hospital Pharmacy Residency at Sunnybrook Health Sciences Centre in 1982. He graduated with a Doctor of Pharmacy from the State University of New York at Buffalo in 1984. From 1985 to the present, Carlo has been the Clinical Pharmacy Coordinator for Oncology at the Odette Cancer Centre, Sunnybrook Health Sciences Centre and has owned and managed a community pharmacy, Panacea Pharmacy since 1994.
He is an Associate Professor in the Division of Pharmacy Practice at the Faculty of Pharmacy, University of Toronto and lectures in both the Undergraduate Bachelor of Science in Pharmacy and Doctor of Pharmacy Programs. He has given numerous presentations at local, national and international meetings on various oncology related topics.

Daniela Gallo-Hershberg, BScPhm, PharmD
Dr. Daniela Gallo-Hershberg is the Oncology Pharmacist Practitioner at North York General Hospital. Dr. Gallo-Hershberg earned her Bachelor of Science in Pharmacy from the University of Toronto in 2003 and completed an Ambulatory Pharmacy Practice Residency at Sunnybrook Health Sciences Centre in 2004.  She graduated with a Doctor of Pharmacy degree from the University of Toronto in 2006.
Dr. Gallo-Hershberg is an Assistant Professor (status) at the Faculty of Pharmacy at the University of Toronto where she coordinates and lectures for the Contemporary Topics in Oncology course in the PharmD for Pharmacists Program.

 

Larry BroadfieldBScPhm, MHSc
Larry Broadfield is is Manager of the Systemic Therapy Program Cancer Care Nova Scotia. He is a Fellow of the Canadian Association of Hospital Pharmacists and a member of numerous professional associations. He has been a member of the Standards Working Group of the Canadian Partnership Against Cancer and has authored many publications on systemic therapy guidelines.

 

 

Lynda G. Balneaves, RN(BC), PhD
Dr. Lynda Balneaves is an Associate Professor in the College of Nursing, University of Manitoba. For the past 20 years she has focused her research on supporting informed treatment decisions in people living with cancer interested in using complementary therapies. Dr. Balneaves is the the Principal Investigator of the Complementary Medicine Education and Outcomes (CAMEO) research program, which has developed and evaluated a variety of education and decision support interventions aimed at helping cancer patients and health professionals make evidence-informed decisions about complementary therapies. She has also conducted health services and policy research on the use of medical cannabis in Canada. Currently, Dr. Balneaves is the President-Elect of the Society for Integrative Oncology (SIO) and is board member for the International Society for Complementary Medicine Research (ISCMR). 

Mova Leung, BScPhm, PharmD, BCOP
Dr. Mova Leung obtained her B.ScPharm and PharmD  at the University of Toronto and a Pharmacy Practice residency at Kaleida Health Systems, Buffalo, NY. She has previously managed pharmacy teams and provided care for people with cancer in out-patient and in-patient settings.  She seeks to promote the pharmacists’ delivery of cancer care in the community.  She is currently the clinical pharmacist lead in the Specialty Pharmacy Services division of McKesson Canada, and is involved in the coordination of clinical services in cancer and autoimmune disease.  She is also involved in research and education through her role as Oncology, Immunology and Hematology Course Coordinator for the Faculty of Pharmacy, University of Toronto.

  Rachel Whitty, BScPhm
Rachel Whitty graduated from the Leslie Dan Faculty of Pharmacy (LDFP) at the University of Toronto (U of T) and completed an accredited hospital pharmacy residency program at University Health Network (UHN) in Toronto.  She was the pharmacist for Princess Margaret Cancer Centre's acute palliative care unit, and served as the centre’s Acting Pharmacy Clinical Site Leader.  Rachel is an Adjunct Lecturer in the LDFP at U of T, she gives annual palliative care lectures for pharmacy students at both U of T and the University of Waterloo, and teaches seminars for palliative care fellows through U of T.  She has been a preceptor and mentor for pharmacy students and residents, regularly presents at conferences about palliative care, and is engaged in interprofessional education about pain and palliative care.  Rachel is currently the UHN Laboratory Medicine Program's Manager of International Partnerships, and is engaged in palliative care research at UHN.     

 

Scott Edwards, BScPhm, PharmD
Dr. Scott Edwards is currently the clinical oncology pharmacy specialist at the Dr. H. Bliss Murphy Cancer Center in St. John’s, NL. He is an assistant professor at the School of Pharmacy and the Discipline of Oncology, Faculty of Medicine, Memorial University of Newfoundland.
Dr. Edwards is active in clinical cancer research in the area of chemotherapy toxicities and supportive care. He graduated from Memorial University of Newfoundland with a B.Sc. (Neuroscience) in 1994 and a B.Sc (Pharmacy) in 1997. In 2005 he graduated with a Doctor of Pharmacy degree from the University of Washington. He has completed a Postgraduate Certificate in Cancer Studies from Newcastle University from Newcastle University, England.  He is currently working on a Masters in Oncology from Newcastle University, England.